newlimit Profile Banner
NewLimit Profile
NewLimit

@newlimit

Followers
19K
Following
30
Media
3
Statuses
80

Working toward radical extension of human healthspan using epigenetic reprogramming.

South San Francisco, CA
Joined October 2021
Don't wanna be here? Send us removal request.
@newlimit
NewLimit
3 months
Thank you @ashleevance for posting this great summary of our work at @newlimit to radically extend human healthspan Visit the careers page on our website (link in follow on post) to join us on this mission
@ashleevance
Ashlee Vance
3 months
Our new @corememory video on @newlimit, which is finding combinations of proteins that reverse aging across the body. It is perhaps the most exciting work in the bio-tech field. Backed by @brian_armstrong @patrickc @collision @JoshuaKushner @natfriedman and others
6
5
67
@jacobkimmel
Jacob Kimmel
10 days
.@newlimit has raised an additional $45M from new investors including Lilly Ventures, Duke University, @S32_VC, @AbstractVC & others. Insiders including @kleinerperkins, @_DimensionCap, @humancapital, @BoostVC also participated. This round was catalyzed by technical
31
45
426
@jacobkimmel
Jacob Kimmel
30 days
through the late summer @newlimit, we've been upgrading our 1st prototype medicines to prepare for human trials highlights - +2 prototype medicines with efficacy in liver disease models - +14 TF payloads that restore function in old T cells - +4000 TF sets tested across
3
11
102
@dwarkesh_sp
Dwarkesh Patel
2 months
"A good way to understand a lot of evolution—and how you're able adapt to new environments or pathogens—is that gene duplication is possible. The real problem is this: if one or two mutations break the gene, and only three mutations together fixes it again, it’s very hard for
@dwarkesh_sp
Dwarkesh Patel
2 months
.@jacobkimmel thinks he can find the transcription factors necessary to reverse aging. 0:00:00 – Three reasons evolution didn't optimize for longevity 0:12:48 – Why didn't humans evolve their own antibiotics? 0:26:08 – De-aging cells via epigenetic reprogramming 0:45:24 – Viral
10
14
153
@jacobkimmel
Jacob Kimmel
2 months
.@dwarkesh_sp has a rare talent for traversing the tree of ideas by stepping upon only the most entropic branches it was a joy to discuss ideas around AI in bio, human evolution, the biology of aging, @newlimit, & the future of therapeutics a few weeks back
@dwarkesh_sp
Dwarkesh Patel
2 months
.@jacobkimmel thinks he can find the transcription factors necessary to reverse aging. 0:00:00 – Three reasons evolution didn't optimize for longevity 0:12:48 – Why didn't humans evolve their own antibiotics? 0:26:08 – De-aging cells via epigenetic reprogramming 0:45:24 – Viral
18
39
367
@dwarkesh_sp
Dwarkesh Patel
2 months
.@jacobkimmel thinks he can find the transcription factors necessary to reverse aging. 0:00:00 – Three reasons evolution didn't optimize for longevity 0:12:48 – Why didn't humans evolve their own antibiotics? 0:26:08 – De-aging cells via epigenetic reprogramming 0:45:24 – Viral
18
59
398
@jacobkimmel
Jacob Kimmel
2 months
improving biology that evolution has optimized is absurdly difficult. one reason for optimism in longevity is that evolution hardly selected for it. even simple interventions can restore function or extend life. it seems likely that medicines turning on just a few key genes can
@dwarkesh_sp
Dwarkesh Patel
2 months
.@jacobkimmel thinks that the functionality to reverse aging already exists in our epigenome. But then why didn't evolution already optimize for longevity? Jacob explains that if you consider evolution as an optimizer, the gradients flow in a really surprising way. Naively,
23
41
383
@byersblake
Blake Byers
2 months
You will definitely want to tune into this pod with my cofounder @jacobkimmel and my favorite podcaster @dwarkesh_sp. Jacob has this rare combination of being super deep in bio and ML (he’s often technically more adept than candidates we interview for nearly every role @newlimit)
@dwarkesh_sp
Dwarkesh Patel
2 months
.@jacobkimmel thinks that the functionality to reverse aging already exists in our epigenome. But then why didn't evolution already optimize for longevity? Jacob explains that if you consider evolution as an optimizer, the gradients flow in a really surprising way. Naively,
5
11
156
@zavaindar
Zavain Dar
3 months
great overview of @_DimensionCap portco @newlimit, pioneering tech in epigenetic reprogramming to ̶s̶l̶o̶w̶ reverse aging in pursuit of future life saving, life extending, medicines
@ashleevance
Ashlee Vance
3 months
Our new @corememory video on @newlimit, which is finding combinations of proteins that reverse aging across the body. It is perhaps the most exciting work in the bio-tech field. Backed by @brian_armstrong @patrickc @collision @JoshuaKushner @natfriedman and others
1
8
57
@jacobkimmel
Jacob Kimmel
3 months
ashlee & the @corememory team are among the best storytellers in science. we were privileged to host them for a look inside @newlimit. we hope this is only the first of many windows into our mission to add healthy years to each life.
@ashleevance
Ashlee Vance
3 months
Our new @corememory video on @newlimit, which is finding combinations of proteins that reverse aging across the body. It is perhaps the most exciting work in the bio-tech field. Backed by @brian_armstrong @patrickc @collision @JoshuaKushner @natfriedman and others
7
8
86
@byersblake
Blake Byers
3 months
NewLimit paper just dropped @icmlconf showing our SOTA AI models can predict perturbed cell states. Helps to have the largest primary cell perturbation dataset in the world. Bonus points for one of the first demonstration of active learning in bio.
10
53
342
@jacobkimmel
Jacob Kimmel
3 months
reprogramming cells with transcription factors is our most expressive tool for engineering cell state traditionally, we found TFs by ~guesswork @icmlconf we're sharing @newlimit's SOTA AI models that can design reprogramming payloads by building on molecular foundation models
5
89
494
@byersblake
Blake Byers
4 months
The research @newlimit over the last quarter has moved my probability that Aging is reversible to 90% and that anti-Aging Medicines will exist to 70%. Still a lot of work to do! That age is a ~plastic state continues to be the secret that the team @newlimit believes while ~the
@jacobkimmel
Jacob Kimmel
4 months
this summer @newlimit, we built our first prototype medicine that restores multiple youthful functions in old hepatocytes. rejuvenating old cells across multiple dimensions seems more possible today than just months ago. recent highlights - +3 TF sets that restore function in
25
41
332
@brian_armstrong
Brian Armstrong
4 months
Important updates from @newlimit on our progress toward curing aging (or at least restoring function that your cells had when you were younger). This is one of the most important and ambitious projects to benefit humanity. Visit the NewLimit careers page on our website to work
@jacobkimmel
Jacob Kimmel
4 months
this summer @newlimit, we built our first prototype medicine that restores multiple youthful functions in old hepatocytes. rejuvenating old cells across multiple dimensions seems more possible today than just months ago. recent highlights - +3 TF sets that restore function in
46
54
484
@newlimit
NewLimit
4 months
RT @jacobkimmel: this summer @newlimit, we built our first prototype medicine that restores multiple youthful functions in old hepatocytes.…
0
4
0
@newlimit
NewLimit
4 months
Check out this interview with our Head of Ops Cathy O'Hare and @EleanorSheekey (link in follow on post)
48
40
75
@BiotechTV
BiotechTV
6 months
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: @newlimit raised a $130M series B round last week to advance its work using epigenetic reprogramming to improve cell function and thus aim to extend longevity. Full video: https://t.co/yaVLnuGUDc
1
3
23
@brian_armstrong
Brian Armstrong
6 months
Congrats to the entire team at @NewLimit, led by @jacobkimmel, Cathy O'Hare, and @byersblake who deserve the credit for making this milestone possible! Exciting progress, and lots to build.
@jeffjohnroberts
Jeff Roberts
6 months
Coinbase founder @brian_armstrong's anti-aging startup just raised a $130M Series B This emerging field of epigenetic reprogramming is fascinating stuff—and AI means it's advancing fast https://t.co/nm3q5135hm
34
30
207